599 related articles for article (PubMed ID: 31345433)
1. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
[TBL] [Abstract][Full Text] [Related]
2. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
Libby P; Sidlow R; Lin AE; Gupta D; Jones LW; Moslehi J; Zeiher A; Jaiswal S; Schulz C; Blankstein R; Bolton KL; Steensma D; Levine RL; Ebert BL
J Am Coll Cardiol; 2019 Jul; 74(4):567-577. PubMed ID: 31345432
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease, Aging, and Clonal Hematopoiesis.
Evans MA; Sano S; Walsh K
Annu Rev Pathol; 2020 Jan; 15():419-438. PubMed ID: 31689371
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
6. Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis.
Snetsinger B; Ferrone CK; Rauh MJ
Methods Mol Biol; 2019; 2045():167-180. PubMed ID: 30941718
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis - Beyond Conventional Cardiovascular Risk Factors.
Zuriaga MA; Fuster JJ
Circ J; 2023 Feb; 87(3):394-400. PubMed ID: 34433749
[TBL] [Abstract][Full Text] [Related]
8. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
9. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
Fuster JJ; Walsh K
Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
[TBL] [Abstract][Full Text] [Related]
10. Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease.
Jung C; Evans MA; Walsh K
Curr Opin Cardiol; 2020 May; 35(3):219-225. PubMed ID: 32073406
[TBL] [Abstract][Full Text] [Related]
11. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
12. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
Saadatagah S; Ballantyne CM
Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904
[TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
15. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
Kumar P; Kopecky SL; Yang EH; Oren O
Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
[TBL] [Abstract][Full Text] [Related]
17. Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease.
Natarajan P
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):3-14. PubMed ID: 36353993
[TBL] [Abstract][Full Text] [Related]
18. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
20. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]